Literature DB >> 26334841

C-reactive protein and the acute phase reaction in geriatric patients.

Thomas Bertsch1, Jakob Triebel2, Cornelius Bollheimer3,4, Michael Christ5, Cornel Sieber3,4, Klaus Fassbender6, Hans Jürgen Heppner7.   

Abstract

The C-reactive protein (CRP), first described as a serum component capable of precipitating the C-polysaccharide of pneumococci, is one of the most important proteins because the serum concentration rises in the acute phase reaction. The acute phase reaction is the nonspecific reaction of the body to noxious stimuli of the most varied kinds, such as infections, burns, neoplasms and tissue trauma. The CRP is synthesized in liver parenchymal cells by cytokines which are derived from stimulated leucocytes and released into the circulation. Because of its molecular structure and in synergy with the complement system, it is able to precipitate and/or lyse microorganisms, thereby rendering them harmless. Measurement of the serum CRP concentration can provide important information with respect to the diagnosis and monitoring of treatment. Due to immunosenescence in geriatric patients the synthesis of CRP appears to be limited to inflammatory stimuli; however, this phenomenon does not appear to be of major clinical relevance. Despite the introduction of new parameters of the acute phase reaction, sometimes with better performance, such as interleukin-6, procalcitonin and the soluble endotoxin receptor sCD14, measurement of CRP for diagnosis and treatment monitoring is still justified even in geriatric patients as testing is rapid, economic and nearly ubiquitously available round the clock. Biochemical markers of the acute phase reaction should always be interpreted together with the clinical picture and their specific limitations.

Entities:  

Keywords:  Acute phase reaction; C-reactive protein; Geriatrics; Infection; Innate immune response

Mesh:

Substances:

Year:  2015        PMID: 26334841     DOI: 10.1007/s00391-015-0938-4

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  49 in total

Review 1.  Regulation of complement activation by C-reactive protein.

Authors:  C Mold; H Gewurz; T W Du Clos
Journal:  Immunopharmacology       Date:  1999-05

2.  Procalcitonin: inflammatory biomarker for assessing the severity of community-acquired pneumonia--a clinical observation in geriatric patients.

Authors:  H J Heppner; T Bertsch; B Alber; A S Esslinger; C Dragonas; J M Bauer; C C Sieber
Journal:  Gerontology       Date:  2009-11-25       Impact factor: 5.140

3.  Subcutaneous administration of recombinant glycosylated interleukin 6 in patients with cancer: pharmacokinetics, pharmacodynamics and immunomodulatory effects.

Authors:  R E Banks; M A Forbes; P M Patel; M Storr; S Hallam; D Clarke; D Novick; E Ingham; C Bowmer; J Southgate; L K Trejdosiewicz; J Illingworth; T J Perren; P J Selby
Journal:  Cytokine       Date:  2000-04       Impact factor: 3.861

Review 4.  Leukocyte function in the aging immune system.

Authors:  Anjali Desai; Annabelle Grolleau-Julius; Raymond Yung
Journal:  J Leukoc Biol       Date:  2010-03-03       Impact factor: 4.962

5.  [Significance of C-reactive protein in pediatric diagnosis].

Authors:  J H Ehrich; F Krull; U Peltner; A Hussein; J Stein
Journal:  Monatsschr Kinderheilkd       Date:  1986-12       Impact factor: 0.323

6.  Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcome.

Authors:  Lene S Knudsen; Mette Klarlund; Henrik Skjødt; Trine Jensen; Mikkel Ostergaard; Karl Erik Jensen; Michael S Hansen; Merete L Hetland; Hans J Nielsen; Julia S Johansen
Journal:  J Rheumatol       Date:  2008-06-15       Impact factor: 4.666

7.  The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo.

Authors:  W L Hutchinson; G E Noble; P N Hawkins; M B Pepys
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

8.  Elevated serum interleukin-6 levels associated with active disease in systemic connective tissue disorders.

Authors:  R A Stuart; A J Littlewood; P J Maddison; N D Hall
Journal:  Clin Exp Rheumatol       Date:  1995 Jan-Feb       Impact factor: 4.473

Review 9.  Inflammatory cytokines in systemic lupus erythematosus.

Authors:  Kim Ohl; Klaus Tenbrock
Journal:  J Biomed Biotechnol       Date:  2011-10-16

10.  THE OCCURRENCE DURING ACUTE INFECTIONS OF A PROTEIN NOT NORMALLY PRESENT IN THE BLOOD : I. DISTRIBUTION OF THE REACTIVE PROTEIN IN PATIENTS' SERA AND THE EFFECT OF CALCIUM ON THE FLOCCULATION REACTION WITH C POLYSACCHARIDE OF PNEUMOCOCCUS.

Authors:  T J Abernethy; O T Avery
Journal:  J Exp Med       Date:  1941-01-31       Impact factor: 14.307

View more
  7 in total

1.  Sulfated polysaccharide ascophyllan from Padina tetrastromatica enhances healing of burn wounds by ameliorating inflammatory responses and oxidative damage.

Authors:  Mohsin Sulaiman; Salem Rashed Alyileili; Mahadevan Raghavankutty; G Muraleedhara Kurup
Journal:  Mol Biol Rep       Date:  2020-11-01       Impact factor: 2.316

2.  The Impact of Prophylactic Lacosamide on LPS-Induced Neuroinflammation in Aged Rats.

Authors:  Mehtap Savran; O Ozmen; Y Erzurumlu; H B Savas; S Asci; M Kaynak
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

3.  An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging.

Authors:  Nazish Sayed; Yingxiang Huang; Khiem Nguyen; Zuzana Krejciova-Rajaniemi; Anissa P Grawe; Tianxiang Gao; Robert Tibshirani; Trevor Hastie; Ayelet Alpert; Lu Cui; Tatiana Kuznetsova; Yael Rosenberg-Hasson; Rita Ostan; Daniela Monti; Benoit Lehallier; Shai S Shen-Orr; Holden T Maecker; Cornelia L Dekker; Tony Wyss-Coray; Claudio Franceschi; Vladimir Jojic; François Haddad; José G Montoya; Joseph C Wu; Mark M Davis; David Furman
Journal:  Nat Aging       Date:  2021-07-12

4.  A randomized controlled trial investigating the effect of a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols on the intestinal microbiome and inflammation in patients with ulcerative colitis: study protocol for a randomized controlled trial.

Authors:  Alireza Milajerdi; Omid Sadeghi; Seyed Davar Siadat; Seyed Ali Keshavarz; Alireza Sima; Homayoon Vahedi; Peyman Adibi; Ahmad Esmaillzadeh
Journal:  Trials       Date:  2020-02-18       Impact factor: 2.279

5.  Surgical injury: comparing open surgery and laparoscopy by markers of tissue damage.

Authors:  Jan Máca; Matúš Peteja; Petr Reimer; Ondřej Jor; Věra Šeděnková; Lucie Panáčková; Peter Ihnát; Michal Burda; Pavel Ševčík
Journal:  Ther Clin Risk Manag       Date:  2018-05-30       Impact factor: 2.423

6.  Systemic infection modifies the neuroinflammatory response in late stage Alzheimer's disease.

Authors:  Sonja Rakic; Yat M A Hung; Matthew Smith; Denise So; Hannah M Tayler; William Varney; Joe Wild; Scott Harris; Clive Holmes; Seth Love; William Stewart; James A R Nicoll; Delphine Boche
Journal:  Acta Neuropathol Commun       Date:  2018-09-07       Impact factor: 7.801

7.  Serum procalcitonin and C-reactive protein in the evaluation of bacterial infection in generalized pustular psoriasis.

Authors:  Siyu Wang; Zhen Xie; Zhu Shen
Journal:  An Bras Dermatol       Date:  2019-09-30       Impact factor: 1.896

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.